Antagonistic epistasis of Hnf4α and FoxO1 metabolic networks through enhancer interactions in β-cell function

Objective: Genetic and acquired abnormalities contribute to pancreatic β-cell failure in diabetes. Transcription factors Hnf4α (MODY1) and FoxO1 are respective examples of these two components and act through β-cell-specific enhancers. However, their relationship is unclear. Methods: In this report,...

Full description

Bibliographic Details
Main Authors: Taiyi Kuo, Wen Du, Yasutaka Miyachi, Prasanna K. Dadi, David A. Jacobson, Daniel Segrè, Domenico Accili
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Molecular Metabolism
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2212877821001010
_version_ 1818741877576302592
author Taiyi Kuo
Wen Du
Yasutaka Miyachi
Prasanna K. Dadi
David A. Jacobson
Daniel Segrè
Domenico Accili
author_facet Taiyi Kuo
Wen Du
Yasutaka Miyachi
Prasanna K. Dadi
David A. Jacobson
Daniel Segrè
Domenico Accili
author_sort Taiyi Kuo
collection DOAJ
description Objective: Genetic and acquired abnormalities contribute to pancreatic β-cell failure in diabetes. Transcription factors Hnf4α (MODY1) and FoxO1 are respective examples of these two components and act through β-cell-specific enhancers. However, their relationship is unclear. Methods: In this report, we show by genome-wide interrogation of chromatin modifications that ablation of FoxO1 in mature β-cells enriches active Hnf4α enhancers according to a HOMER analysis. Results: To model the functional significance of this predicted unusual enhancer utilization, we generated single and compound knockouts of FoxO1 and Hnf4α in β-cells. Single knockout of either gene impaired insulin secretion in mechanistically distinct fashions as indicated by their responses to sulfonylurea and calcium fluxes. Surprisingly, the defective β-cell secretory function of either single mutant in hyperglycemic clamps and isolated islets treated with various secretagogues was completely reversed in double mutants lacking FoxO1 and Hnf4α. Gene expression analyses revealed distinct epistatic modalities by which the two transcription factors regulate networks associated with reversal of β-cell dysfunction. An antagonistic network regulating glycolysis, including β-cell “disallowed” genes, and a synergistic network regulating protocadherins emerged as likely mediators of the functional restoration of insulin secretion. Conclusions: The findings provide evidence of antagonistic epistasis as a model of gene/environment interactions in the pathogenesis of β-cell dysfunction.
first_indexed 2024-12-18T02:03:36Z
format Article
id doaj.art-4238f9e1168c468b80aa8a3a188fa866
institution Directory Open Access Journal
issn 2212-8778
language English
last_indexed 2024-12-18T02:03:36Z
publishDate 2021-11-01
publisher Elsevier
record_format Article
series Molecular Metabolism
spelling doaj.art-4238f9e1168c468b80aa8a3a188fa8662022-12-21T21:24:40ZengElsevierMolecular Metabolism2212-87782021-11-0153101256Antagonistic epistasis of Hnf4α and FoxO1 metabolic networks through enhancer interactions in β-cell functionTaiyi Kuo0Wen Du1Yasutaka Miyachi2Prasanna K. Dadi3David A. Jacobson4Daniel Segrè5Domenico Accili6Department of Medicine and Berrie Diabetes Center, Columbia University College of Physicians and Surgeons, New York, NY, USA; Corresponding author. Department of Medicine and Berrie Diabetes Center, Columbia University College of Physicians and Surgeons, 1150 St. Nicholas Avenue, Room 237, New York, NY, 10032, USA.Department of Medicine and Berrie Diabetes Center, Columbia University College of Physicians and Surgeons, New York, NY, USADepartment of Medicine and Berrie Diabetes Center, Columbia University College of Physicians and Surgeons, New York, NY, USADepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USADepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USADepartment of Biology, Department of Biomedical Engineering, Department of Physics, Boston University, Boston, MA, USADepartment of Medicine and Berrie Diabetes Center, Columbia University College of Physicians and Surgeons, New York, NY, USAObjective: Genetic and acquired abnormalities contribute to pancreatic β-cell failure in diabetes. Transcription factors Hnf4α (MODY1) and FoxO1 are respective examples of these two components and act through β-cell-specific enhancers. However, their relationship is unclear. Methods: In this report, we show by genome-wide interrogation of chromatin modifications that ablation of FoxO1 in mature β-cells enriches active Hnf4α enhancers according to a HOMER analysis. Results: To model the functional significance of this predicted unusual enhancer utilization, we generated single and compound knockouts of FoxO1 and Hnf4α in β-cells. Single knockout of either gene impaired insulin secretion in mechanistically distinct fashions as indicated by their responses to sulfonylurea and calcium fluxes. Surprisingly, the defective β-cell secretory function of either single mutant in hyperglycemic clamps and isolated islets treated with various secretagogues was completely reversed in double mutants lacking FoxO1 and Hnf4α. Gene expression analyses revealed distinct epistatic modalities by which the two transcription factors regulate networks associated with reversal of β-cell dysfunction. An antagonistic network regulating glycolysis, including β-cell “disallowed” genes, and a synergistic network regulating protocadherins emerged as likely mediators of the functional restoration of insulin secretion. Conclusions: The findings provide evidence of antagonistic epistasis as a model of gene/environment interactions in the pathogenesis of β-cell dysfunction.http://www.sciencedirect.com/science/article/pii/S2212877821001010Beta cellHnf4aFoxo1EnhancerInsulinEpistasis
spellingShingle Taiyi Kuo
Wen Du
Yasutaka Miyachi
Prasanna K. Dadi
David A. Jacobson
Daniel Segrè
Domenico Accili
Antagonistic epistasis of Hnf4α and FoxO1 metabolic networks through enhancer interactions in β-cell function
Molecular Metabolism
Beta cell
Hnf4a
Foxo1
Enhancer
Insulin
Epistasis
title Antagonistic epistasis of Hnf4α and FoxO1 metabolic networks through enhancer interactions in β-cell function
title_full Antagonistic epistasis of Hnf4α and FoxO1 metabolic networks through enhancer interactions in β-cell function
title_fullStr Antagonistic epistasis of Hnf4α and FoxO1 metabolic networks through enhancer interactions in β-cell function
title_full_unstemmed Antagonistic epistasis of Hnf4α and FoxO1 metabolic networks through enhancer interactions in β-cell function
title_short Antagonistic epistasis of Hnf4α and FoxO1 metabolic networks through enhancer interactions in β-cell function
title_sort antagonistic epistasis of hnf4α and foxo1 metabolic networks through enhancer interactions in β cell function
topic Beta cell
Hnf4a
Foxo1
Enhancer
Insulin
Epistasis
url http://www.sciencedirect.com/science/article/pii/S2212877821001010
work_keys_str_mv AT taiyikuo antagonisticepistasisofhnf4aandfoxo1metabolicnetworksthroughenhancerinteractionsinbcellfunction
AT wendu antagonisticepistasisofhnf4aandfoxo1metabolicnetworksthroughenhancerinteractionsinbcellfunction
AT yasutakamiyachi antagonisticepistasisofhnf4aandfoxo1metabolicnetworksthroughenhancerinteractionsinbcellfunction
AT prasannakdadi antagonisticepistasisofhnf4aandfoxo1metabolicnetworksthroughenhancerinteractionsinbcellfunction
AT davidajacobson antagonisticepistasisofhnf4aandfoxo1metabolicnetworksthroughenhancerinteractionsinbcellfunction
AT danielsegre antagonisticepistasisofhnf4aandfoxo1metabolicnetworksthroughenhancerinteractionsinbcellfunction
AT domenicoaccili antagonisticepistasisofhnf4aandfoxo1metabolicnetworksthroughenhancerinteractionsinbcellfunction